Back to news
Regulatory debate over synthetic peptides and gray market access
ONE REPORT·Published ·Event date ·Main source · CNBC
Story essentials
Department of Health and Human Services, Robert F. Kennedy Jr., Health experts
USA
February 2026
Original reports
The US Department of Health and Human Services is considering an interim policy to allow compounding of certain synthetic peptides.
Health experts warn against the use of unapproved injectable peptides due to safety risks and lack of clinical evidence.
Consumer interest is rising, fueled by the success of FDA-approved GLP-1 drugs.
This page is produced by collecting and structuring multiple public reports. Sections based only on reporting or testimony affect the displayed assessment, and the page is updated when new information is identified.
About this article
COMPAMIR Editorial Team
The COMPAMIR editorial team brings together public reporting and links to the original coverage. We update the page as new information emerges.
Read our editorial policyRead next
Prioritized by shared people, places, and events.
US Postal Service releases Diwali stamp, prints 20 mn copies
The US Postal Service has issued a commemorative stamp for the festival of Diwali. A total of 20 million copies of the stamp have been printed.